These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23872148)

  • 21. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
    Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
    Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
    Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ
    Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of VHL tumourigenesis in nerve root tissue.
    Vortmeyer AO; Tran MG; Zeng W; Gläsker S; Riley C; Tsokos M; Ikejiri B; Merrill MJ; Raffeld M; Zhuang Z; Lonser RR; Maxwell PH; Oldfield EH
    J Pathol; 2006 Nov; 210(3):374-82. PubMed ID: 16981244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
    Turner KJ; Moore JW; Jones A; Taylor CF; Cuthbert-Heavens D; Han C; Leek RD; Gatter KC; Maxwell PH; Ratcliffe PJ; Cranston D; Harris AL
    Cancer Res; 2002 May; 62(10):2957-61. PubMed ID: 12019178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.
    Baba M; Hirai S; Yamada-Okabe H; Hamada K; Tabuchi H; Kobayashi K; Kondo K; Yoshida M; Yamashita A; Kishida T; Nakaigawa N; Nagashima Y; Kubota Y; Yao M; Ohno S
    Oncogene; 2003 May; 22(18):2728-38. PubMed ID: 12743597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathology, genetics and cell biology of hemangioblastomas.
    Wizigmann-Voos S; Plate KH
    Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of HIF-1A and its implication in the hypoxia pathway in primary advanced uterine cervical carcinoma.
    Łuczak MW; Roszak A; Pawlik P; Kędzia H; Lianeri M; Jagodziński PP
    Oncol Rep; 2011 Nov; 26(5):1259-64. PubMed ID: 21887475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
    Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of von Hippel-Lindau tumor suppressor protein and antisense HIF-1alpha eradicates gliomas.
    Sun X; Liu M; Wei Y; Liu F; Zhi X; Xu R; Krissansen GW
    Cancer Gene Ther; 2006 Apr; 13(4):428-35. PubMed ID: 16211089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
    Wykoff CC; Pugh CW; Maxwell PH; Harris AL; Ratcliffe PJ
    Oncogene; 2000 Dec; 19(54):6297-305. PubMed ID: 11175344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review.
    Vriend J; Reiter RJ
    Biochim Biophys Acta; 2016 Apr; 1865(2):176-83. PubMed ID: 26899267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of VHL gene mutation in human cancer.
    Kim WY; Kaelin WG
    J Clin Oncol; 2004 Dec; 22(24):4991-5004. PubMed ID: 15611513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.
    Shively SB; Edwards NA; MacDonald TJ; Johnson KR; Diaz-Rodriguez NM; Merrill MJ; Vortmeyer AO
    J Neuropathol Exp Neurol; 2022 Oct; 81(11):885-899. PubMed ID: 35980299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
    Kanno H; Yoshizumi T; Shinonaga M; Kubo A; Murata H; Yao M
    J Neurooncol; 2020 May; 148(1):29-38. PubMed ID: 32356150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VHL and PTEN loss coordinate to promote mouse liver vascular lesions.
    Chen S; Sanford CA; Sun J; Choi V; Van Dyke T; Samulski RJ; Rathmell WK
    Angiogenesis; 2010 Mar; 13(1):59-69. PubMed ID: 20221685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
    Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
    Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.